Sti-571 in Chronic Myelogenous Leukaemia-Reference-Cited by-同舟云学术

Sti-571 in Chronic Myelogenous Leukaemia

Published:2002-10 Issue:1 Volume:119 Page:15-24
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Tsao Anne S.,Kantarjian Hagop,Talpaz Moshe

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2002.03899.x/fullpdf

Reference72 articles.

1. UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia;Allan;Lancet,1995

2. American Society of Hematology Education Program Book. Non-Transplant Treatment Options for Patients with Newly Diagnosed Chronic Myelogenous Leukemia;Baccarani;American Society of Hematology Education Program Book,2001

3. A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia;Baccarani;Blood,2002

4. Roots of clinical resistance to STI-571 cancer therapy;Barthe;Science,2001

5. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia;Bartram;Nature,1983

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Kinases in Hematological Disorders;Advances in Experimental Medicine and Biology;2021

2. Management of pregnant chronic myeloid leukemia patients;Expert Review of Hematology;2016-07-07

3. TYROSINE KINASE INHIBITORS AND PREGNANCY;Mediterranean Journal of Hematology and Infectious Diseases;2014-04-07

4. The Effect of Treatment for Chronic Myeloid Leukemia: Meta- Analysis;Journal of Korean Society of Health-System Pharmacists;2013-08

5. Cleavage of BCR–ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR–ABL leukemic cells;Leukemia;2013-02-25